Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02381886
Title A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

IDH305

Age Groups: adult
Covered Countries USA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST